Vieworks to Unveil Dual Imaging TDI Camera at automatica 2025
ANYANG, South Korea, June 18, 2025 /PRNewswire/ -- Vieworks, a global leader in machine vision solutions, will unveil its latest advancements in machine vision technology at automatica 2025, held in Munich, Germany, from June 24 to 27 (Hall B5,...
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the ADA's 85th Scientific Sessions
SAN FRANCISCO and SUZHOU, China, June 13, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
51Talk Online Education Group to Present on the Emerging Growth Conference on June 17, 2025.
51Talk Online Education Group invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference. SINGAPORE, June 12, 2025 /PRNewswire/ -- 51Talk...
Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025
Caliway to deliver a corporate presentation on June 17 at the BIO International Convention 2025, the world's largest biotech industry event. For the first time at an international conference, Caliway will share preclinical results on CBL-514's...
Fashion Walk x ADAHK Present: "CHEER Creative Art Week"
Two Murals by Artists with Disabilities Brighten Up Food Street @ Fashion Walk Interactive Workshops and Sharing Sessions Explore the Boundless Possibilities of Creativity Exclusive "CHEER-TOMATO" Plushies and Hang Lung e-Gift Vouchers Giveaways...
J INTS BIO to Present Global Clinical Results from JIN-A02, a Fourth-Generation EGFR-TKI, at ASCO 2025
Significant anti-tumor responses and reduction of brain metastases observed SEOUL, South Korea , June 2, 2025 /PRNewswire/ -- J INTS BIO, a company specializing in the development of therapeutics for cancer and rare diseases, officially announced...
Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025
ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), achieved an overall response rate (ORR) of 36.4% and disease control rate (DCR) of 100% in checkpoint inhibitor (CPI)-resistant...
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting
Abstract Released for E7386, Co-Developed Through Collaborative Research Between Eisai and PRISM TOKYO, May 23, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule...
Dizal to Present Promising Clinical Data on Golidocitinib and DZD8586 for the Treatment of Lymphoma at the Coming International Hematology Conferences
The latest 2-year follow-up data on golidocitinib as a maintenance therapy for peripheral T-cell lymphoma (PTCL) patients who achieved tumor response after first-line systemic therapy will be presented orally at the 2025 ICML A pooled safety and...
APMIC Unveils Next-Gen Model Fine-Tuning & Distillation Solution, Powered by NVIDIA Blackwell, at COMPUTEX 2025
First Software Provider in Taiwan to Integrate NVIDIA B200 GPU, Enhancing Computing Performance and Inference Accuracy to Overcome Enterprise AI Bottlenecks TAIPEI, May 15, 2025 /PRNewswire/ -- APMIC, a global pioneer in delivering enterprise-grade...